Colorectal Cancer
Clinical Trials

1) Phase 1B single agent cohort part of Mirati 849-001/USO 19151: Cohort F – A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation CRC with KRAS G12C mutation – 21 SLOTS AVAILABLE! USOR will NOT participate in the cohort sub-studies nor the fed state (food effect) cohort.

Send UsA Message

    Jenny’s Journey Reflects Our Mission

    Jenny’s Journey Reflects Our Mission

    At Charleston Oncology, the mission of healing all people with compassion, faith and excellence resonates through the hallways and translates into every patient interaction.

    read more
    Myra Walks in a Patient’s Shoes

    Myra Walks in a Patient’s Shoes

    In the busy corridors of Charleston Oncology on a triple-booked day of patients, a moment of pure human kindness unfolded, illustrating what it truly means to walk in a patient’s shoes.

    read more
    Call Now Button